Key Words: FDG-positron emission tomography/computed tomography, Warthin tumor, cervical lymph node metastasis 18 F -Fluorodeoxyglucose positron emission tomography/ computed tomography (FDG-PET/CT) is a highly effective diagnostic modality for staging in patients with head and neck cancer. 1, 2 It is also applied to assess treatment response as well as detect unknown primary cancer, secondary cancer, and distant metastasis.
1,2 However, cancer patients can sometimes be misdiagnosed due to false-positive FDG uptake caused by inflammation, infection, or benign tumors. We report FDG-positive Warthin tumor (WT) in a contralateral cervical lymph node that mimicked tongue cancer metastasis on PET/CT.
CLINICAL REPORT
A 77-year-old female smoker was referred to our department with pain of the right lateral border of the tongue. The lesion with ulcer on the lateral border of the tongue was 18 Â 13 mm. After incisional biopsy, pathological diagnosis was squamous cell carcinoma. Contrast-enhanced CT showed an enlarged cervical lymph node (15 Â 11 Â 10 mm) at contralateral level II (Fig. 1 ). FDG-PET/CT revealed maximum standardized uptake values of the primary site and the contralateral cervical lymph node were 2.2 g/mL and 3.7 g/mL, respectively ( Fig. 2 ). There was no distant metastasis. As salivary gland tumor in the lymph node or contralateral lymph node metastasis was suspected, fine-needle aspiration of the lymph node was performed for N-staging. However, the cells on the fine-needle biopsy were red blood cells and inflammatory cells. Therefore, excisional biopsy was performed. Histopathological examination revealed oncocytic cells lined a cystic space, and there was a dense population of lymphocytes in the stroma (Fig. 3) . The features were typical of WT. Therefore, we diagnosed tongue cancer as T2N0M0 and the patient underwent only partial glossectomy. The patient's postoperative course was uneventful, and there has been no recurrence and metastasis 6 years after surgery.
DISCUSSION
WT is the second most common benign parotid tumor, and extraparotid WTs are extremely rare and sometimes can be multicentric. 3 Most extraglandular WTs occur in the periparotid lymph node at level II or III and involve ectopic salivary gland tissue in the lymph node. 1Y6 The incidence of such tissue in the lymph node was reported to be 12% (31/257 oral cancer patients who underwent neck dissection). 7 Malignant transformation of WT is extremely rare, with an incidence of 0.07Y0.3%. 8 WTs in the cervical lymph nodes mimicking metastasis in oral and oropharyngeal cancer patients have been reported previously by several authors, 1Y5 and all WTs were in ipsilateral lymph nodes. 1Y5 As most enlarged lymph nodes result in the misdiagnosis of metastasis, extraglandular WTs are usually discovered as an incidental finding on pathological examination of neck dissection for primary oral cancer.
1,2,4,5 To our knowledge, the present case of tongue cancer is the first report of WT in a contralateral cervical lymph node mimicking metastasis in oral cancer. Contralateral cervical lesion in oral cancer patients must be managed carefully to avoid redundant neck dissection. Therefore, we reported this case with educational value since the differential diagnosis of a cervical mass is important as N-staging can affect the treatment.
Although extension of a primary oral cancer to the midline increases the risk of contralateral lymph node metastasis, Woolgar 9 reported a low incidence of 2.5% (9/359 patients). Tongue cancer concomitant with only contralateral lymph node metastasis is extremely rare, with an incidence of 0.9% (1/116 patients). 9 Moreover, 1 of 83 patients (1.2%) with cancer of the lateral border of the tongue staged pN2c had only contralateral lymph node metastasis. 9 Because we suspected benign tumor in the lymph node rather than only contralateral lymph node metastasis on FDG-PET/CT in a patient with cancer of the lateral border of the tongue, we performed excisional biopsy to confirm the N stage and the lymph node lesion was diagnosed as WT.
The role of FDG-PET/CT has come to be more important in the diagnosis and staging of head and neck cancer in recent years. However, FDG uptake is not specific for malignant tumors. Despite the high accuracy of FDG-PET/CT, there are potential pitfalls of FDG uptake by adipose tissue, musculature, inflammatory tissue, and salivary gland. 2, 10 It is important to recognize FDG uptake to avoid false interpretation of benign normal variant as a malignant finding on FDG-PET/CT scans. WT is known to be a benign tumor with high FDG uptake, 1,2 and Schwarz et al 1 and Enomoto et al 2 have reported FDG-positive WTs in cervical lymph nodes that mimicked oral cancer metastasis on FDG-PET/CT. The average maximum standardized uptake value of WT in the lymph nodes including our patient data is 5.8 g/mL (3.7Y9.5 g/mL).
1,2
The differential diagnosis of lymph node metastasis and WT is difficult, and we should be aware of the potential pitfalls of FDG-PET/CT to avoid inaccurate staging for oral cancer. 1 Although the synchronous manifestation of oral cancer and WT in the lymph node is extremely rare, WT should be taken into consideration in differential diagnosis when evaluating cervical mass at level II or III.
